Archive · 26 Aug 2026
Lord’s Mark and ARKALL Plan Healthcare Expansion Across Caribbean
Lord’s Mark Industries is an Indian healthcare company partnering with ARKALL Holdings in the Caribbean.
They plan to build and operate laboratories that test medical samples.
They also want to sell medical devices, equipment, dialysis machines and other healthcare products.
The project will start in Trinidad & Tobago.
It is expected to expand to all 28 Caribbean countries over three years.
ARKALL will pay for the expansion and help develop the markets.
Lord’s Mark will provide products, training, technical advice and operational support.
The company estimates that the project could produce about US$100 million in export revenue from FY27 to FY31.
It also estimates a potential pathology and diagnostics market worth about US$1.24 billion.
Lord’s Mark Industries and ARKALL Holdings will establish pathology laboratories and commercialise healthcare products across 28 Caribbean countries.
The phased rollout will begin with market assessment and planning in Trinidad & Tobago before expanding over three years.
ARKALL will fund the expansion and lead commercialisation, while Lord’s Mark will supply products and provide technical and operational support.
Lord’s Mark projects approximately US$100 million in export revenue between FY27 and FY31 from the Caribbean rollout.
The company estimates the pathology and diagnostics opportunity across the 28 markets at approximately US$1.24 billion.
- Who
- Lord’s Mark Industries Limited and ARKALL Holdings Limited.
- What
- A strategic collaboration to establish pathology laboratories and commercialise medical devices, equipment and healthcare products across 28 Caribbean countries.
- When
- Announced August 25; the phased expansion is planned over the next three years, with projected export revenue between FY27 and FY31.
- Where
- The initiative will begin in Trinidad & Tobago and expand across the Caribbean; the announcement was issued from Mumbai, Maharashtra, India.
- Why
- To expand access to diagnostics and healthcare technology while creating a regional platform for Lord’s Mark’s exports.
- Partners
- Lord’s Mark Industries Limited and ARKALL Holdings Limited
- Initial market
- Trinidad & Tobago
- Planned reach
- All 28 Caribbean countries
- Expansion timeline
- Progressive rollout over three years
- Projected export revenue
- Approximately US$100 million between FY27 and FY31
- Estimated market opportunity
- Approximately US$1.24 billion in pathology and diagnostics across the 28 markets
- Investment responsibility
- ARKALL Holdings Limited will undertake the required expansion investments
